Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Assets Average: 2011-2024

Historic Assets Average for Sunshine Biopharma (SBFM) over the last 10 years, with Dec 2024 value amounting to $29.0 million.

  • Sunshine Biopharma's Assets Average rose 6.90% to $31.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year increase of 6.90%. This contributed to the annual value of $29.0 million for FY2024, which is 2.33% up from last year.
  • As of FY2024, Sunshine Biopharma's Assets Average stood at $29.0 million, which was up 2.33% from $28.3 million recorded in FY2023.
  • Sunshine Biopharma's 5-year Assets Average high stood at $29.0 million for FY2024, and its period low was $571,808 during FY2020.
  • Its 3-year average for Assets Average is $24.3 million, with a median of $28.3 million in 2023.
  • Its Assets Average has fluctuated over the past 5 years, first dropped by 8.12% in 2020, then skyrocketed by 868.08% in 2022.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Assets Average stood at $571,808 in 2020, then spiked by 184.04% to $1.6 million in 2021, then surged by 868.08% to $15.7 million in 2022, then skyrocketed by 79.96% to $28.3 million in 2023, then climbed by 2.33% to $29.0 million in 2024.